相关实验视频

Updated: Jul 16, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

富含AT相互作用域1A突变癌症的临床和突变特征

Rosa Falcone¹, Marco Filetti¹, Pasquale Lombardi¹

¹Phase 1 Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Exploration of targeted anti-tumor therapy

|September 15, 2023

概括

这项研究分析了270名癌症患者,发现9%的人患有ARID1A基因变异,主要是患有妇科癌症的女性. ARID1A突变与较高的瘤突变负担和特定的同时发生的突变有关,这表明了潜在的新疗法策略.

科学领域:

在瘤学瘤学.
遗传学是一个遗传学.
分子生物学分子生物学

背景情况:

富含AT相互作用域1A (ARID1A) 基因对SWI/SNF染色体重塑复合体至关重要,影响基因表达.
在各种癌症中经常观察到ARID1A的变化,但它们的确切作用和临床影响需要进一步研究.

研究的目的:

为了研究ARID1A突变的癌症患者的临床和分子特征.
在ARID1A突变癌症中识别常见的同时发生的突变和潜在的治疗标.

主要方法:

分析了270名癌症患者的分子和临床数据.
FoundationOne® CDx测定用于分子分析,以确定ARID1A的变化.
如果患者至少有一种致病性ARID1A变异,则被归类为ARID1A阳性 (ARID1A+).

主要成果:

9%的患者 (25/270) 呈现了ARID1A变异,主要是患有早期妇科癌症的女性 (84%) (60%).
与ARID1A阴性患者相比,ARID1A+患者的突变数量和瘤突变负担 (TMB) 更高.
在ARID1A+组中富含突变包括PIK3CA,PTEN,CTNNB1和MLL2. 在ARID1A状态和对化疗反应之间没有发现任何关联.

结论:

这项研究为ARID1A突变癌症,特别是妇科亚型提供了详细的临床和分子见解.
在子宫内膜内膜癌中PIK3CA的频繁共变表明,结合ATR和PIK3CA抑制剂的潜在治疗策略.

关键词:

富含AT的交互领域1A 癌症癌症癌症癌症癌症突变是一种突变.目标目标目标目标目标目标目标.

更多相关视频

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

The Ras Gene

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Mutagenicity and Carcinogenicity

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...